Evidence map›Paper›PMID 30107854›Full record

ArticleStem cell research & therapy2018

Inhibition of mTORC1 signaling protects kidney from irradiation-induced toxicity via accelerating recovery of renal stem-like cells.

Lijian Shao, Wuping Yang, Rui Xu, Shuqin Zhu, Yanqiu Huang, Huan Li, Xincheng Wu, Mengzhen Yue, Xiaoliang Xiong, Xiaowen Chen and 4 more

Open access · goldAbstract read
In one paragraph

Article in Stem cell research & therapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Deinoxanthin Recovers HAntioxidants (Basel, Switzerland) · 2025
    Article
  2. Article
  3. Rapamycin Ameliorates Radiation-Induced Testis Damage in Mice.Frontiers in cell and developmental biology · 2022
    Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Lijian ShaoJiangxi Provincial Key Laboratory of Preventive Medicine, Nanchang University, Nanchang, 330006, China.
Wuping YangJiangxi Provincial Key Laboratory of Preventive Medicine, Nanchang University, Nanchang, 330006, China.
Rui XuDepartment of Histology and Embryology, Basic Medical School of Nanchang University, No. 461 Bayi Road, Nanchang, 330006, China.
Shuqin ZhuDepartment of Pathology, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, 519000, China.
Yanqiu HuangThe First Affiliated Hospital of Nanchang University, Nanchang, 330006, China.
Huan LiDepartment of Histology and Embryology, Basic Medical School of Nanchang University, No. 461 Bayi Road, Nanchang, 330006, China.
Xincheng WuDepartment of Histology and Embryology, Basic Medical School of Nanchang University, No. 461 Bayi Road, Nanchang, 330006, China.
Mengzhen YueDepartment of Histology and Embryology, Basic Medical School of Nanchang University, No. 461 Bayi Road, Nanchang, 330006, China.
Xiaoliang XiongDepartment of Pathology, Basic Medical School of Nanchang University, Nanchang, 330006, China.
Xiaowen ChenThe First Affiliated Hospital of Nanchang University, Nanchang, 330006, China.
Bohai KuangDepartment of Medical Genetics and Cell Biology, Basic Medical School of Nanchang University, Nanchang, 330006, China.
Guangqin FanJiangxi Provincial Key Laboratory of Preventive Medicine, Nanchang University, Nanchang, 330006, China.
Qingxian ZhuDepartment of Histology and Embryology, Basic Medical School of Nanchang University, No. 461 Bayi Road, Nanchang, 330006, China.
Huihong ZengDepartment of Histology and Embryology, Basic Medical School of Nanchang University, No. 461 Bayi Road, Nanchang, 330006, China. zenghuihong@ncu.edu.cn.
Nanchang University · CNFifth Affiliated Hospital of Sun Yat-sen University · CNFirst Affiliated Hospital of Nanchang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIrradiation-induced kidney damage is inevitable during radiotherapeutic practice, which limits effective radiotherapy doses on tumor treatment. In the present study, the role of mTOR complex 1 (mTORC1) signaling was investigated in irradiation-induced renal injuries.

methodsMice were exposed to 8.0-Gy X-ray of total body irradiation and subsequently treated with rapamycin. Changes of renal morphology were assessed by hematoxylin and eosin staining. Expression of pS6 and CD133 was detected via immunostaining. Cellular apoptosis and proliferation were measured by TUNEL, caspase-3 and BrdU staining. Activation of mTORC1, TGF-β and NF-κB signaling pathways was determined through western blot analysis.

resultsOur data displayed that irradiation disrupted the structures of renal corpuscles and tubules and decreased the density of CD133

conclusionsThese findings indicate that inhibition of mTORC1 signaling by rapamycin ameliorates irradiation-induced renal toxicity mediated by decreasing cellular apoptosis and increasing CD133

Indexed as

AnimalsApoptosisHumansKidneyMaleMechanistic Target of Rapamycin Complex 1MiceSignal TransductionStem CellsMechanistic Target of Rapamycin Complex 1ApoptosisIrradiationmTOR complex 1RapamycinRenal damage

Identifiers

PMID30107854
PMCPMC6092808
OpenAlexW2886254998

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.